SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001347178-21-000008
Filing Date
2021-04-22
Accepted
2021-04-22 07:01:03
Documents
5
Period of Report
2021-06-10

Document Format Files

Seq Description Document Type Size
1 DEF 14A vnda-20210422xdef14a.htm DEF 14A 1317324
2 proxycard2021page11a.jpg GRAPHIC 257305
3 proxycard2021page21a.jpg GRAPHIC 289069
4 proxyimage1a011a.jpg GRAPHIC 24955
5 slide11a.jpg GRAPHIC 105113
  Complete submission text file 0001347178-21-000008.txt   2238907
Mailing Address 2200 PENNSYLVANIA AVE NW SUITE 300E WASHINGTON DC 20037
Business Address 2200 PENNSYLVANIA AVE NW SUITE 300E WASHINGTON DC 20037 202-734-3400
Vanda Pharmaceuticals Inc. (Filer) CIK: 0001347178 (see all company filings)

IRS No.: 030491827 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-34186 | Film No.: 21843232
SIC: 2834 Pharmaceutical Preparations